In terms of insulin resistance, the function of RELMβ might be similar to that of resistin. Peripheral infusion of RELMβ impaired insulin action in the liver. 17 Transgenic mice expressing RELMβ in the liver reportedly exhibited insulin resistance with hyperinsulinemia, hyperglycemia, hyperlipidemia, and fatty liver when consuming a high-fat diet. Furthermore, glucose absorption in the intestinal tract was suggested to involve RELMβ. 18 Based on these previous reports, we attempted to clarify the association of RELMβ expression levels in the intestinal tract with the pathophysiology of chronic inflammation in humans. During this investigation, unexpectedly, we found that considerable percentages of macrophages in gut connective tissue stained for the anti-RELMβ antibody, although staining intensities differed among individuals.
This finding led to the speculation that macrophages might possess the potential to express RELMβ when exposed to certain stimuli or conditions and raised the possibility that RELMβ contributes to atherosclerosis development. Herein, we present the first evidence showing the critical role of RELMβ in the development of atherosclerosis using human atherosclerotic coronary arteries and RELMβ knockout ( −/− ) mice, as well as in vitro data, suggesting possible molecular mechanisms underlying the processes of atherosclerosis induction.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Expression of RELMβ in Atherosclerotic Lesions
The monoclonal antibodies against human RELMβ were generated by immunizing mice with amino acids 14 to 66 of RELMβ fused with glutathione S-transferase ( Figure I in the online-only Data Supplement). As reported previously, epithelial cells, particularly goblet cells, were strongly stained in the intestine ( Figure IIA in the online-only Data Supplement). However, some macrophages in the villi of the intestine contained considerable amounts of RELMβ ( Figure IIB in the online-only Data Supplement).
Because foam cells in unstable plaques in the aorta would be derived from highly activated macrophages via many factors, an immunohistochemical analysis using 3A-6 antihuman RELMβ monoclonal antibody was performed on 10 autopsied human coronary arteries from subjects who had died of acute myocardial infarction ( Figure 1 ). RELMβ was abundantly expressed in macrophages in atherosclerotic lesions of all 10 samples, without exception, and representative staining is shown in Figure 1A . The enlarged picture ( Figure 1B) revealed RELMβ staining to be dot-like in the cytoplasm, likely reflecting the presence of RELMβ in secretory vesicles. The staining with anti-CD68 and anti-RELMβ antibodies was performed for tissues of atherosclerotic lesions, as well as tissues outside the aorta, using adjacent slides ( Figure 1C ). It was shown that enlarged macrophages in plaques are both CD68 and RELMβ positive, whereas RELMβ was not detected in the small CD68-positive cells in normal fat tissue around the artery ( Figure 1C ). In plaques, double staining by anti-CD68 (green) and anti-RELMβ (red) antibodies confirmed the RELMβ-expressing cells to be macrophages ( Figure 1D ).
RELMβ −/− ApoE −/− Mice Showed Amelioration of Atherosclerotic Change Without Changes in Serum Lipid Profiles Compared With RELMβ +/+ ApoE −/− Mice
We generated RELMβ −/− mice with exon 2 to 4 deletions of the RELMβ gene using gene targeting technology ( Figure III in the online-only Data Supplement). Then, we prepared RELMβ −/− mice with the C57Bl6 background using marker-assisted breeding 19 and examined the expressions of RELMβ in the colons of RELMβ +/+, +/−, and −/− mice. RELMβ expression in RELMβ +/+ was very low under specific pathogen-free conditions but markedly increased under conventional conditions, whereas none was detected in RELMβ −/− mice under either condition. The colonic expression level in RELMβ +/− mice was significantly lower than that in RELMβ +/+ mice, but was still readily detectable ( Figure IVA These mice were subjected to investigation of lipid accumulations in the aortic root ( Figure 2A and 2C) at the ages of 3 and 6 months. Oil Red O staining of the aortic roots from RELMβ −/− mice with the ApoE −/− background showed significantly reduced lipid accumulation compared with their littermates. The area immunohistochemically stained with anti-macrophage antibodies in the aortic roots from 6-monthold RELMβ −/− ApoE −/− mice was also significantly reduced compared with their littermates. The change started from 3 months of age and was significant at 6 months.
Subsequently, the atherosclerotic lesions in the aortas of 12-month-old mice were subjected to Oil Red O staining ( Figure 2B , 2D, and 2E). Quantification analysis revealed the ratios of areas with fat deposition to whole aortic wall areas to be significantly lower in RELMβ −/− ApoE −/− or RELMβ +/− ApoE −/− mice than in RELMβ +/+ ApoE −/− mice ( Figure 2D ). The numbers of these areas in whole aortic areas were also lower in RELMβ −/− ApoE −/− mice ( Figure 2E ). RELMβ +/− ApoE −/− mice showed a significant reduction in the Oil Red O-stained area compared with RELMβ +/+ ApoE −/− mice, but the reduction in the number of areas was not significant.
Furthermore, by crossing with low-density lipoprotein receptor (LDLR) −/− mice, RELMβ −/−, +/−, and +/+ mice with the LDLR −/− background were generated. These mice were fed a high-cholesterol diet from the age of 3 months for 8 weeks. It was demonstrated that RELMβ −/− LDLR −/− mice showed marked amelioration of atherosclerotic lesions compared with RELMβ +/+ LDLR −/− mice, which is similar to that of ApoE −/− mice ( Figure 2F ).
RELMβ Promotes Macrophage Foam Cell Formation
The in vitro effect of RELMβ expression on macrophage foam cell formation was investigated ( Figure 3A and 3B). PCPMs were obtained from RELMβ −/− mice and their littermates 2 days after peritoneal injection of thioglycholate (TGC) and treated with 50 µg/mL oxidized LDL, 50 µg/mL VLDL, or 1% sera from 3-month-old WHHL rabbits. Incubation with oxidized LDL, VLDL, or WHHL rabbit serum induced significant lipid accumulation in PCPMs, and quantification of cellular lipids was performed by staining with AdipoRed assay reagent and adjusted for cell counts. RELMβ −/− macrophages accumulated significantly smaller amount of lipids than RELMβ +/+ macrophages (Figure 3B*). In contrast, administration of 2 µg/mL recombinant RELMβ increased lipid accumulation in RELMβ −/− PCPMs ( Figure 3B †) , which was blocked by coincubation with 50 µg/mL anti-RELMβ F(ab′)2 antibody ( Figure 3B# ).
Next, 1,1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanice (Dil)-acetyl LDL uptake for 4 hours was assayed and then adjusted by cell numbers ( Figure 3C ). 1,1-dioctadecyl-3,3,3,3tetramethylindocarbocyanice (Dil)-acetyl LDL uptake into RELMβ −/− PCPMs was significantly lower than that into RELMβ +/+ PCPMs. Similarly, [ 3 H]-cholesterol efflux by high-density lipoprotein uptake was slightly but significantly decreased by RELMβ deficiency ( Figure 3D ).
Alterations in the expressions of lipoprotein receptors, scavenger receptors (SRs), and lipid transporters were investigated ( Figure 3E ). Absence of RELMβ significantly reduced protein levels of SR-A1 and VLDL receptor. SR-A2 and Lox-1 mRNA levels in the RELMβ +/+ PCPMs were markedly elevated by stimulation with lipopolysaccharide (LPS), and the degree of LPS-induced increase was markedly attenuated in RELMβ −/− PCPMs. LDLR and CD36 expression levels did not differ between RELMβ +/+ and RELMβ −/− PCPMs. As for lipid efflux transporters, the ATP binding cassette G1 protein level was upregulated but that of ATP binding cassette A1 was reduced, and SR-B1 also tended to be reduced in RELMβ −/− PCPMs compared with RELMβ +/+ 
RELMβ Enhances the Expressions of Inflammatory Cytokines and the Nuclear Factor-κB Pathway With LPS Stimulation in Macrophages
To reveal the proinflammatory effects of RELMβ on macrophages, LPS-induced mRNA expressions of inflammatory cytokines in PCPMs from RELMβ −/− mice and their littermates 2 days after TGC peritoneal injection were examined by quantitative polymerase chain reaction ( Figure 4A ). The inductions of TNFα, interleukin (IL)-1β, and IL-6 by incubation with 10 ng/mL LPS for 4 hours were very high in PCPMs from RELMβ +/+ mice, and these inductions were significantly blunted in the absence of RELMβ. In addition, inductions of inflammatory cytokine secretions by recombinant human RELMβ (hRELMβ) administration were investigated in phorbol 12-myristate 13-acetate-differentiated human cell lines THP-1 and U-937 ( Figure VIA and VIB in the online-only Data Supplement). Supernatants from THP-1 or U-937 cell culture treated with 3 g/mL hRELMβ or human resistin for 24 hours were collected, and concentrations of TNFα, IL-1β, and IL-6 were determined using a Bioplex kit. hRELMβ markedly increased the secretions of TNFα, IL-1β, and IL-6. In contrast, resistin had no effects on these cytokine secretions.
Next, LPS-induced nuclear factor (NF)-κB activation was investigated. After stimulation with 100 ng/mL LPS, time-dependent changes in the protein expressions and phosphorylation levels of NF-κB and IκB kinase-α/β were compared between the PCPMs from RELMβ −/− mice and their littermates ( Figure 4B ). Degradation of IκB by 100 n/mL LPS in the presence of cycloheximide was also investigated. Although protein expression levels of NF-κB and IκB kinase-α/β did not differ between PCPMs from RELMβ −/− mice and their littermates, phosphorylation levels of NF-κB and IκB kinase-α/β were significantly lower in the RELMβ −/− than in the RELMβ +/+ PCPMs. IκB degradation by LPS stimulation was also restored in the absence of RELMβ at 60 minutes in the presence of cycloheximide, thus IκB degradation by LPS was delayed in RELMβ −/− macrophages. These data suggest that RELMβ exerts an enhancing effect on LPS-induced NF-κB activation.
RELMβ Is Expressed in CD11c-Positive Cells, and the Absence of RELMβ Blunted the Inflammatory Response
Peritoneal macrophages from RELMβ +/+ and RELMβ −/− mice were collected from RPMI1640 medium 2 days after addition of PBS, 10% proteose peptone, or 3% TGC injection. Cells were stained with F4/80, CD11c, CD206, and RELMβ and then analyzed by flow cytometry (Figure VIIA Next, we investigated whether extracellular administration of RELMβ affects the M1/M2 markers of PCPMs and whether extracellular administration of neutralizing antibody can block the effects of RELMβ on M1/M2 markers. The peritoneal macrophages from RELMβ +/+, +/−, and −/− mice were collected after stimulation with or without TGC injection, and the PCPMs obtained were incubated with 100 ng/mL of LPS for 4 hours. TGC treatment markedly increased expressions of CD11c, TNFα, and CD206 in RELMβ −/− macrophages, whereas IL-10 decreased the expressions of these macrophages (Figure VIII* in the onlineonly Data Supplement). The effects of TGC on CD11c, TNFα, CD206, and IL-10 were significantly suppressed in 
RELMβ Is Upregulated by Stimulation With Saturated Fatty Acids in Human Macrophage Cell Lines
The regulation of RELMβ expression in the human macrophage cell lines THP-1 and U-937 was investigated using real-time polymerase chain reaction. RELMβ expression levels in these cell lines were very low under basal conditions but showed marked induction when incubated with 0.2 mmol/L SFA, such as stearic and palmitic acids, for 16 hours. Unsaturated fatty acids were less effective for RELMβ induction. In contrast, resistin expression levels were not altered by either SFA (Figure IXA and IXB in the online-only Data Supplement). In addition, the degrees of SFA-induced TNFα and IL-6 expressions were significantly lower in RELMβ −/− than in RELMβ +/+ PCPMs ( Figure IXC in the online-only Data Supplement).
Discussion
RELMβ expression was formerly thought to be limited to epidermal, particularly goblet, cells of the small and large intestines and bronchial tracts. 9, 12 In these tissues, RELMβ reportedly contributes to protection against infections with parasitic worms or bacteria and also functions to maintain barrier integrity. 14, 20 In agreement with such functions, RELMβ expression in the gut is reportedly induced on exposure to a conventional environment after being in a germ-free environment. 21 Furthermore, RELMβ has been suggested to be involved in a variety of human inflammatory gastrointestinal conditions, including allergic gastroenteropathies, 20 airway remodeling, 22 and pulmonary hypertension. 23 In contrast to the aforementioned reports, the first surprising finding of this study was the high expression of RELMβ in the foam cells of atherosclerotic lesions, which was demonstrated in both human autopsy samples and the aortas of ApoE −/− and LDLR −/− mice. RELMβ detection in atherosclerotic lesions was limited to the large, foam cell macrophages in plaques, with none being found in the small CD68-positive macrophages scattered in the surrounding normal adipose tissue. In this study, it was shown that very LDL-rich WHHL serum in murine PCPMs and SFA in human macrophage cell lines markedly upregulated the expression of RELMβ. Thus, in contrast to the continuous expression of resistin in macrophages, RELMβ expression in macrophages is likely to be induced by certain stimulants, such as specific pathological states.
To examine the contribution of RELMβ to the pathogenesis of atherosclerosis, we generated RELMβ −/− mice with the ApoE −/− or LDLR −/− background. Indeed, these mice showed significantly less lipid accumulation in the aortic root and aortic wall than RELMβ +/+ with ApoE −/− or LDLR −/− mice. Absence of RELMβ does not result in significant changes in serum lipid profiles, which indicates that macrophagederived RELMβ directly contributes to lipid accumulation in macrophages and the development of atherosclerosis.
It is well known that atherosclerosis develops through multiple processes, among which foam cell formation is a key event, because it leads to the secretion of inflammatory cytokines 24 and plaque instability. 25 It was revealed in vitro that RELMβ induced macrophages to induce NF-κB signaling and express inflammatory cytokines, lipid uptake, and also promoted their transformation into foam cells. NF-κB signaling is reportedly involved in not only inflammatory responses but also foam cell formation. 26 In this study, it was demonstrated that RELMβ induces the transformation of macrophages into foam cells. Furthermore, cellular mechanisms lead to foam cell transformations, such as lipid uptake, metabolism, efflux, and, governed by their respective SRs, expressions of lipases, hydroxylase, and ATP binding cassette transporters. 27, 28 It was previously documented that intraperitoneal injection of RELMβ enlarged murine peritoneal macrophages. 29 We speculated that lipid accumulation would be the explanation for this observation and then demonstrated that RELMβ −/− PCPMs accumulated smaller amounts of lipid when incubated with various lipoproteins. In the lipid uptake assay, RELMβ −/− showed diminished lipoprotein uptake, but lipid efflux was also diminished by RELMβ deficiency. Extracellular recombinant RELMβ administration to RELMβ −/− PCPMs and J774.1 cells results in expression changes of SRs and lipid transporters, such as lipoprotein receptors (LDLR, VLDL receptor) and class A (SR-A1) and B (CD36) SRs. Class A is a group of receptors for oxidized LDL and acLDL. Cholesterol efflux and highdensity lipoprotein-dependent lipid transporters (SR-B1, ATP binding cassette A1) were downregulated in RELMβ −/− macrophages, whereas lipid uptake, especially of modified LDL and VLDL, was phenotypically predominant.
RELMβ activates the classical M1 macrophage marker CD11c and inflammatory cytokines, and absence of RELMβ reduces inducible CD11c-positive and CD206-positive cells. In contrast, major portion of inflammation-induced CD11c-or CD206-positive cells are RELMβ positive. CD11c-positive cells are reportedly important for foam cell formation 30 and constitute a major cell population in atherosclerotic plaque. 31 RELMβ is essential for the induction of CD11c-positive cells, and a direct effect was demonstrated by administration of RELMβ. The number of CD206positive macrophages is paradoxically increased by peritoneal TGC injection, although IL-10, an anti-inflammatory cytokine, is decreased. The latter effect is partially reversed by neutralization of extracellular RELMβ. CD206-positive, alternatively activated M2 macrophages are generally antiinflammatory, but also have a role in foam cell formation. 32 Induction of CD206-positive cells is speculated to provide a degree of compensation but is not sufficient to overcome the inflammatory phenotype, and RELMβ in CD206-positive cells suggests inhibition of IL-10 expression.
Taking into consideration that macrophages themselves produce RELMβ and that serum RELMβ (on the order of several nanograms per milliliter in mice) concentrations would not reach those necessary to function in macrophages, it is possible that RELMβ produced by foam cells functions in macrophages in either a paracrine or an autocrine manner. We demonstrated that extracellular RELMβ can induce inflammation, lipid accumulation, and gene regulations by recombinant RELMβ administration and neutralization of inflammation by its blocking antibody.
Our results strongly suggest that RELMβ, which is abundantly expressed in the foam cells of atherosclerotic lesions, functions in both autocrine and paracrine manners in M1/ M2 macrophages, endothelial cells, and fibroblasts (data not shown), thereby contributing to atherosclerosis development and plaque instability ( Figure X in the online-only Data Supplement). Thus, an agent suppressing RELMβ expression or an antagonist of the as yet unidentified receptor might be used to prevent or treat atherosclerosis. In addition, serum RELMβ concentrations might serve as a marker for judging the degree of atherosclerosis. Further study, particularly for identification of the RELMβ receptor and to assess the value of measuring the serum RELMβ concentration, is needed.
